Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 8:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 1,602 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Major Depressive Disorder
Interventions: Selegiline Transdermal System, Placebo; Drug
Lead sponsor: Somerset Pharmaceuticals; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 308 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 20
States / cities: Dothan, Alabama • National City, California • San Diego, California + 17 more

Conditions: Dry Age-related Macular Degeneration, Geographic Atrophy
Interventions: Surgical implantation of the CPCB-RPE1 implant; Device
Lead sponsor: Regenerative Patch Technologies, LLC; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2040
U.S. locations: 5
States / cities: Huntington Beach, California • Los Angeles, California • Lemont, Illinois + 2 more

Conditions: Tobacco Dependence
Interventions: Varenicline, Nicotine patch, Placebo Patch, Placebo Pill; Drug · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 1,251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Port Wine Stains
Interventions: Imiquimod, non-medicated petroleum cream; Drug
Lead sponsor: Henry Vasconez; Other
Eligibility: 2 Years to 60 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: HIV Infection, HIV Infections
Interventions: Efavirenz + Tenofovir DF/Emtricitabine, Raltegravir + Tenofovir DF/Emtricitabine, Colonoscopy with biopsies, Inguinal Lymph Node Excision; Drug · Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Amblyopia, Binocular Vision Disorder
Interventions: Binocular cartoon treatment at home, Patching, Binocular cartoon treatment in office; Other
Lead sponsor: University of Waterloo; Other
Eligibility: 36 Months to 83 Months
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Migraine Disorders
Interventions: NP101 - Sumatriptan iontophoretic transdermal patch, Placebo; Drug
Lead sponsor: NuPathe Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 34
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Newport Beach, California + 31 more

Conditions: Cigarette Smoking, Smoking Cessation
Interventions: Contingency Management (CM), Transdermal nicotine skin patches (i.e. Habitrol), Supportive Counseling; Behavioral · Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Daytrana; Drug
Lead sponsor: Noven Therapeutics; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 29
States / cities: Scottsdale, Arizona • Irvine, California • San Marcos, California + 26 more

Conditions: Forehead; Wound
Interventions: Group 1 cannabidiol (CBD) with silicone ointment, Group 2 silicone patch; Biological
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 99 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Advanced Parkinson's Disease
Interventions: Rotigotine, Placebo; Drug
Lead sponsor: UCB Pharma; Industry
Eligibility: 30 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 26
States / cities: Birmingham, Alabama • Gilbert, Arizona • Fountain Valley, California + 23 more

Conditions: Tobacco Dependence
Interventions: ProChange ExpertSystem; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: Menlo Park, California • San Francisco, California • San Rafael, California

Conditions: Vitamin D Deficiency
Interventions: Transdermal D Patch, Oral vitamin D3, Placebo patch, Oral placebo; Dietary Supplement
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Smoking Cessation, Smoking, Cigarette, Smoking Reduction, Smoking, Smoking, Tobacco, Quitting Smoking
Interventions: 4 weeks of Nicotine lozenge, 8 weeks of Nicotine Replacement Therapy Patch, QuitAid, Smokefree TXT, Tobacco Quitline, 4 weeks of Nicotine Replacement Therapy Patch, 8 Weeks Nicotine Lozenge; Drug · Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 768 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Healthy
Interventions: CHG Catheter Dressing Patch, Biopatch, Tegaderm CHG; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Smoking Cessation
Interventions: varenicline (CP-526,555); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 6
States / cities: Palo Alto, California • Santa Ana, California • Farmington, Connecticut + 3 more

Conditions: Compare Bioequivalence Patches Previously Used in the NP101-007 Study
Interventions: NP101, sumatriptan succinate; Drug
Lead sponsor: NuPathe Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Smoking Cessation, HIV
Interventions: Combination Therapy, Standard Care Intervention; Other
Lead sponsor: dr. maria miguez; Other
Eligibility: 18 Years and older
Enrollment: 488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Medical Device Complication, Brain Injuries, Brain Diseases, Stroke, Vasospasm
Interventions: conventional transcranial Doppler probe and wearable ultrasound patch.; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Smoking Cessation
Interventions: Telephone Counseling, Nicotine Patches; Behavioral · Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Diego, California

Conditions: Premature Labor
Interventions: Abdominal fetal/maternal monitoring; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Allergic Sensitization
Interventions: Light Therapy Mask Cream; Device
Lead sponsor: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Union, New Jersey

Conditions: Smoking Cessation, Smoking, Nicotine Dependence
Interventions: Nicotine patch, Cessation Counseling, Mobile Games; Drug · Behavioral · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Tobacco Use Disorder
Interventions: Pharmacotherapies for Smoking Cessation; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 20 Years to 65 Years
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

UW Quitting Using Intensive Treatment Study (QUITS)

The Effects of Aldara as an Adjunct to Laser Treatment

Raltegravir Activity In Lymphoid Tissues

A Patch Free Treatment for Young Children With Amblyopia

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Contingency Management, Quitting Smoking, and ADHD

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Topical CBD Scar Outcomes Study

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction

Tobacco Treatment for Employable Californians, Total IMPACT Study

Evaluation of a Transdermal Vitamin D3 Delivery System, D3forME

Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia

Components of Chlorhexidine Gluconate Dressing

An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Patch Study - Intervention for HIV Positive Smokers

Transcranial Doppler Using Wearable Ultrasound Patch

Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging

Performance of the Monica Novii Wireless Patch System in Pre-term Labor

Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100

A Quit Smoking Study Using Smartphones

Bupropion as an Adjunct to the Nicotine Patch Plus CBT